新奥精准精选免费提供,新澳天天开奖正版资料,港 彩资料,新奥资料大全正版2025

?Dr. Wang is a Doctor of medicine in hepatology, visiting scholar in the United States and Hongkong, and clinical fellow in integrated traditional Chinese and Western medicine. She has successively studied hepatology with the world's top hepatologists in Michigan,USA, Hong Kong and Guangzhou, China. During her visit to Hong Kong, she was mainly engaged in the clinical research of new drugs for hepatitis C and cancer. She has published the research results of hepatitis B reactivation, as the first author, in Clinical Gastroenterology and Hepatology, the official journal of gastroenterology in the United States, and Hepatology, the world's top hepatology journal. This study was cited by the American guidelines for the treatment of chronic hepatitis C, and the FDA issued a Black box warning for new drugs of hepatitis C, so the drug instructions of anti-hepatitis C drugs were revised. This study is also cited in the treatment guidelines of chronic hepatitis B of the European Society of Hepatology.